Dr. Baker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin
Ste 1260
Houston, TX 77030Phone+1 713-797-0466Fax+1 713-797-0451
Summary
- Dr. Kelty Baker is a hematologist in Houston, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Hospital and Baylor St. Luke's Medical Center. She received her medical degree from Baylor College of Medicine and has been in practice 24 years. She also speaks multiple languages, including Spanish. She is experienced in thrombocytopenia, hodgkin's lymphoma, multiple myeloma, deep vein thrombosis, and thrombotic disorders.
Education & Training
Baylor College of MedicineFellowship, Hematology, 1997 - 1999- Baylor College of MedicineResidency, Internal Medicine, 1993 - 1997
- Baylor College of MedicineClass of 1993
Certifications & Licensure
TX State Medical License 1994 - 2026
FL State Medical License 2012 - 2021- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- President of the Medical Staff Houston Methodist Hospital, 2019-2020
- Top Doctors:SE Texas Castle Connolly, 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 2 citationsEstablishing a multidisciplinary taskforce to improve anticoagulation safety at a large health system.Engie Attia, Amaris Fuentes, Mark L. Vassallo, Stuart Dobbs, Peter T. Nguyen
American Journal of Health-System Pharmacy. 2021-11-01 - 5 citationsIncidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-cen...Veronica B Ajewole, James E. Cox, Joshua T. Swan, Soumya Chikermane, Beverly Lamoth
Supportive Care in Cancer. 2020-04-01 - 15 citationsDelayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis.Barry H. Trachtenberg, Rammurti T. Kamble, Lawrence Rice, Raquel Araujo-Gutierrez, Arvind Bhimaraj
American Journal of Transplantation. 2019-10-01
Press Mentions
Reader Responses: How Would You Treat This 38-Year-Old Patient with Sickle Cell Trait and End-Stage Renal Disease?June 1st, 2021
Professional Memberships
- Member
- Member
- International Society of Thrombosis and HaemostasisMember
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
